Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Announces Issuance of CRA Cannabis Licence and Board and Management Changes

February 21, 2020


Burlington, Ontario – February 21, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce receipt of its Canada Revenue Agency (CRA) Cannabis Licence in February 2020, and now has obtained all approvals for cannabis processing and packaging for...

Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product

February 4, 2020


Burlington, Ontario – February , 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce the company has secured government funding of $400,000 from The National Research Council of Canada Industrial Research Assistance (NRC-IRAP), to support a project focused...

Rapid Dose Therapeutics and McMaster University Awarded NSERC Research and Development Grant to Develop Oral Dissolvable Film for Enhanced Drug Delivery

January 23, 2020


Burlington, Ontario – January , 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce their newest research partnership program entitled “Rapid Delivery of Therapeutics via Dissolution of Polymeric Films” with McMaster University, located in Hamilton, Ontario, Canada. This...

Rapid Dose Therapeutics Announces Shareholder Meeting Voting Results and New Chief Financial Officer

December 6, 2019


Burlington, Ontario – December , 2019 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce that all of the nominees listed in the Corporation’s management information circular dated November 11, 2019 were elected as directors of the Corporation at...

Health Canada Grants Micro-Processing Licence to Rapid Dose

November 19, 2019


BURLINGTON, Ontario – November 19, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Corporation”) (CSE: DOSE) today reported that is has been issued a micro-processing licence by Health Canada for its Burlington, Ontario facility in accordance with the Cannabis Act and Cannabis Regulations. “This...

Rapid Dose Reports Second Quarter Financial Results, Provides Operations Update and Closes Private Placement

October 30, 2019


BURLINGTON, Ontario – October 30, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Corporation”) (CSE: DOSE) today reported its financial results for the second quarter of fiscal 2020, which ended on August 31, 2019. “We are very pleased to announce the recognition of revenue...

Rapid Dose Therapeutics Announces First Closing of Private Placement

October 9, 2019


BURLINGTON, Ontario, October 9, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Corporation”) (CSE: DOSE) is pleased to announce that today it has completed the first closing of a private placement of common shares in the capital of the Corporation (“Common Shares”) at a...

Rapid Dose Therapeutics Announces Research Results Published in Frontiers in Pharmacology Journal

September 12, 2019


Burlington, ON, September 12, 2019 — Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the results of a research study conducted by the University of Nevada, Las Vegas (“UNLV”) was published in the high impact journal, Frontiers in Pharmacology, on September 10, 2019....

Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Aphria Inc.

September 10, 2019


Burlington, Ontario – September 10, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the installation and commissioning of its QuickStrip™ production equipment at Aphria Inc. (“Aphria”) (TSX: APHA and NYSE: APHA) has been completed pursuant to the terms of the Managed...

Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation in Puerto Rico and Grants Stock Options

September 4, 2019


Burlington, Ontario – September 4, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the installation of its QuickStrip™production equipment at Chemesis International Inc. (“Chemesis”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is now complete, enabling the immediate recognition of revenue to RDT...

1 2 3 4 5 6